Serum palmitoleate acts as a lipokine in subjects at high cardiometabolic risk

Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
J MerinoL Masana

Abstract

Clinical data on the role as a lipokine of de novo lipogenesis-derived palmitoleic acid (C16:1n-7cis) in serum non-esterified fatty acids (palmitoleate) are scarce. We aimed to assess whether palmitoleate relates to cardiometabolic risk. In this cross-sectional study we included 358 individuals aged 30-65-years at high cardiovascular risk. We tested the association of palmitoleate (determined by gas chromatography) with metabolic syndrome (MS) and its components (defined by ATPIII criteria), fatty liver index (a surrogate of non-alcoholic fatty liver disease [NAFLD]), and subclinical atherosclerosis (determined as ultrasound-measured carotid intima-media thickness and arterial stiffness). Palmitoleate concentration was higher in women compared with men (median ± range interquartile, 1.36 ± 0.96 vs. 0.97 ± 0.77 μmol/L respectively, P < 0.001). In both genders palmitoleate concentration was associated with a higher prevalence of MS: men, odds ratio [OR: 1.12 (95%CI: 1.03; 1.23, P = 0.010)]; women [OR: 1.07 (95%CI: 1.03; 1.13, P = 0.005)], and all of its components except low HDL-cholesterol and hypertriglyceridemia. Palmitoleate was also associated with increased risk of NAFLD in both men [OR: 1.12 (95%CI: 1.03; 1.29, P = 0.031)]...Continue Reading

References

Apr 26, 2008·Progress in Lipid Research·Leanne HodsonBarbara A Fielding
Nov 6, 2009·Diabetes Care·Norbert StefanHans-Ulrich Häring
Nov 26, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Puneet PuriArun J Sanyal
Nov 19, 2010·The American Journal of Clinical Nutrition·Jian GongAna Baylin
Jan 27, 2011·Journal of Lipid Research·Elisa FabbriniSamuel Klein
Jul 22, 2011·The New England Journal of Medicine·Joseph F PolakRalph B D'Agostino
May 25, 2012·The British Journal of Nutrition·Javier Aranceta, Carmen Pérez-Rodrigo
Nov 15, 2012·The Journal of Clinical Endocrinology and Metabolism·Bryan C BergmanMarian Rewers
Jan 18, 2013·Current Opinion in Clinical Nutrition and Metabolic Care·Leanne Hodson, Fredrik Karpe
Sep 17, 2013·Liver International : Official Journal of the International Association for the Study of the Liver·Sofia CarvalhanaHelena Cortez-Pinto

❮ Previous
Next ❯

Citations

Aug 14, 2018·Molecular Nutrition & Food Research·Camila Oliveira de SouzaPhilip C Calder
Dec 27, 2019·World Journal of Stem Cells·Antonio Casado-DíazJosé Manuel Quesada-Gómez
Aug 12, 2021·Scientific Reports·Yuko AkazawaFuminao Takeshima

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.